Co-trifamole (Co-Fram - Abbott) is a new combination of a sulphonamide, sulphamoxole, and trimethoprim for oral use. It is similar to co-trimoxazole (sulphamethoxazole + trimethoprim; various brands) and co-trimazine (sulphadiazine + trimethoprim; Coptin),1 which has recently been withdrawn from the UK market. The manufacturer claims co-trifamole to be effective in lower dosage and therefore with fewer dose-dependent adverse effects.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.